keyword
https://read.qxmd.com/read/38618204/safety-and-efficacy-of-once-daily-dexfadrostat-phosphate-in-patients-with-primary-aldosteronism-a-randomised-parallel-group-multicentre-phase-2-trial
#21
JOURNAL ARTICLE
Paolo Mulatero, Gregoire Wuerzner, Michael Groessl, Elisa Sconfienza, Aikaterini Damianaki, Vittorio Forestiero, Bruno Vogt, Hans Brunner, Teresa Gerlock, Ronald Steele, Christoph Schumacher
BACKGROUND: Primary aldosteronism (PA) is caused by autonomous aldosterone overproduction and characterised by uncontrolled hypertension. There are currently no treatments that target aldosterone synthesis. We evaluated the safety and efficacy of a novel aldosterone synthase inhibitor, dexfadrostat phosphate, in patients with PA. METHODS: This multi-centre, randomised, phase 2 trial was conducted between November 2019 and May 2022 (NCT04007406; EudraCT code 2019-000919-85)...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38617865/anatomical-variations-encountered-during-adrenal-venous-sampling-a-report-of-three-case-series-and-review-of-literature
#22
Juyoung Pak, Hyoung Nam Lee, Myung Sub Kim, Hyerim Park
Primary aldosteronism is a group of disorders in which the autonomous secretion of aldosterone is associated with hypertension and hypokalemia. It is crucial to determine the laterality of aldosterone hypersecretion because treatment options differ accordingly. Adrenal venous sampling (AVS) is considered the most reliable method for assessing the laterality of primary aldosteronism. This procedure is often technically challenging because of the small size and varied locations of the adrenal veins. A better understanding of anatomical variations and careful review of imaging studies would improve sampling success...
March 2024: J Korean Soc Radiol
https://read.qxmd.com/read/38616212/systematic-review-article-new-drug-strategies-for-treating-resistant-hypertension-the-importance-of-a-mechanistic-personalized-approach
#23
REVIEW
Giulia Nardoianni, Barbara Pala, Alessandra Scoccia, Massimo Volpe, Emanuele Barbato, Giuliano Tocci
Resistant hypertension (RHT) is characterized by persistently high blood pressure (BP) levels above the widely recommended therapeutic targets of less than 140/90 mmHg office BP, despite life-style measures and optimal medical therapies, including at least three antihypertensive drug classes at maximum tolerated dose (one should be a diuretic). This condition is strongly related to hypertension-mediated organ damage and, mostly, high risk of hospitalization due to hypertension emergencies or acute cardiovascular events...
April 14, 2024: High Blood Pressure & Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension
https://read.qxmd.com/read/38616031/effect-of-resuscitation-of-cryopreserved-porcine-adrenal-glands-at-26%C3%A2-c-on-their-recovery-and-functioning-under-xenotransplantation
#24
JOURNAL ARTICLE
Shasha Li, Lingling Fan, Ustichenko Viktoria, Pakhomov Oleksandr, Zhongjie Li, Wenlu Zhang, Bo Deng
The study is devoted to the effect of lowered resuscitation temperature (26 °C) on cryopreserved porcine adrenal glands functional activity in vitro and in vivo under xenotransplantation. The adrenals were collected from newborn pigs, cryopreserved with 5% DMSO at a rate of 1 °C/min, resuscitated at 26 or 37 °C for 48 hours (5% CO2 , DMEM), embedded into small intestinal submucosa, and transplanted to bilaterally adrenalectomized rats. It has been shown that the glands resuscitated at 26 °C have suppressed free-radical processes and can produce cortisol and aldosterone in vitro, and may lead to elevated blood levels of these hormones...
April 12, 2024: Cryobiology
https://read.qxmd.com/read/38614780/the-emerging-pillars-of-chronic-kidney-disease-no-longer-a-bystander-in-metabolic-medicine
#25
REVIEW
Alexa Wonnacott
Chronic kidney disease (CKD) represents an enormous healthcare burden, the management of which has been stagnant for the last couple of decades, with blockade of the renin-angiotensin-aldosterone system (RAAS) the most potent tool available to retard kidney disease progression. In the new cardiometabolic era, sodium-glucose cotransporter-2 inhibitors (SGLT2i) have emerged as forerunners in addressing combined cardiorenal risk. This review summarises the evidence for SGLT2i use in diabetic and non-diabetic CKD and examines the risk:benefit profile in this population...
May 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38613623/a-fatal-misdiagnosis-of-page-kidney-case-report
#26
JOURNAL ARTICLE
Gayan Kumarasinghe, Murugupillai Sivasubramanium, Kasun Bandara Ekanayake, Dhanushka Rambukwella, Bandarage Sanjaya
Page kidney is a condition where external compression of the renal artery and renal parenchyma leads to subsequent ischaemia and activation of renin-angiotensin-aldosterone axis. A 42-year-old female with hirsutism, hypertension and diabetes was diagnosed with a right adrenal mass and underwent laparoscopic adrenalectomy. Her hypertension worsened postoperatively and was managed medically. Subsequently she developed a right flank pain on the fifth postoperative day and died suddenly the next day. Autopsy revealed a pale body with cushingoid appearance...
April 13, 2024: Forensic Science, Medicine, and Pathology
https://read.qxmd.com/read/38612843/renin-angiotensin-aldosterone-system-from-history-to-practice-of-a-secular-topic
#27
REVIEW
Sara H Ksiazek, Lilio Hu, Sebastiano Andò, Markus Pirklbauer, Marcus D Säemann, Chiara Ruotolo, Gianluigi Zaza, Gaetano La Manna, Luca De Nicola, Gert Mayer, Michele Provenzano
Renin-angiotensin-aldosterone system (RAAS) inhibitors are standard care in patients with hypertension, heart failure or chronic kidney disease (CKD). Although we have studied the RAAS for decades, there are still circumstances that remain unclear. In this review, we describe the evolution of the RAAS and pose the question of whether this survival trait is still necessary to humankind in the present age. We elucidate the benefits on cardiovascular health and kidney disease of RAAS inhibition and present promising novel medications...
April 4, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612779/molecular-targets-of-novel-therapeutics-for-diabetic-kidney-disease-a-new-era-of-nephroprotection
#28
REVIEW
Alessio Mazzieri, Francesca Porcellati, Francesca Timio, Gianpaolo Reboldi
Diabetic kidney disease (DKD) is a chronic microvascular complication in patients with diabetes mellitus (DM) and the leading cause of end-stage kidney disease (ESKD). Although glomerulosclerosis, tubular injury and interstitial fibrosis are typical damages of DKD, the interplay of different processes (metabolic factors, oxidative stress, inflammatory pathway, fibrotic signaling, and hemodynamic mechanisms) appears to drive the onset and progression of DKD. A growing understanding of the pathogenetic mechanisms, and the development of new therapeutics, is opening the way for a new era of nephroprotection based on precision-medicine approaches...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611907/computational-binding-study-hints-at-ecdysone-20-mono-oxygenase-as-the-hitherto-unknown-target-for-ring-c-seco-limonoid-type-insecticides
#29
JOURNAL ARTICLE
Ramsés E Ramírez, Ricardo E Buendia-Corona, Ivonne Pérez-Xochipa, Thomas Scior
The insecticidal property of ring C-seco limonoids has been discovered empirically and the target protein identified, but, to date, the molecular mechanism of action has not been described at the atomic scale. We elucidate on computational grounds whether nine C-seco limonoids present sufficiently high affinity to bind specifically with the putative target enzyme of the insects (ecdysone 20-monooxygenase). To this end, 3D models of ligands and the receptor target were generated and their interaction energies estimated by docking simulations...
April 5, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38610066/eight-weeks-of-treatment-with-mineralocorticoid-receptor-blockade-does-not-alter-vascular-function-in-individuals-with-and-without-type-2-diabetes
#30
JOURNAL ARTICLE
Stine H Finsen, Mie R Hansen, Pernille B L Hansen, Stefan P Mortensen
Aldosterone has been suggested to be involved in the microvascular complications observed in type 2 diabetes. We aimed to investigate the effect of mineralocorticoid receptor (MR) blockade on endothelial function in individuals with type 2 diabetes compared to healthy controls. We included 12 participants with type 2 diabetes and 14 controls. We measured leg hemodynamics at baseline and during femoral arterial infusion of acetylcholine and sodium nitroprusside before and 8 weeks into treatment with MR blockade (eplerenone)...
April 2024: Physiological Reports
https://read.qxmd.com/read/38606689/factors-affecting-the-aldosterone-level-in-heart-failure
#31
JOURNAL ARTICLE
Yusuf Ziya Şener, Gamze Yeter Arslan, Metin Okşul
No abstract text is available yet for this article.
April 12, 2024: Acta Cardiologica
https://read.qxmd.com/read/38606228/alkindi-sprinkle-for-pediatric-patients-with-primary-adrenocortical-insufficiency-a-narrative-review
#32
REVIEW
Alan D Kaye, Munira E Khaled, Kristin Nicole Bembenick, John Lacey, Anamika Tandon, Rucha A Kelkar, Alyssa G Derouen, Corrado Ballaera, Debbie Chandler, Shahab Ahmadzadeh, Sahar Shekoohi, Giustino Varrassi
Adrenocortical insufficiency, also known as adrenal insufficiency (AI), is an endocrine disorder characterized by inadequate production of adrenal hormones, including glucocorticoids and mineralocorticoids (MCs). The condition can be categorized as primary, secondary, or tertiary AI, depending on the location of the defect. Classical symptoms of AI include weakness, fatigue, abdominal pain, tachycardia, hypotension, electrolyte imbalances, and hyperpigmentation. In children, the most common cause of AI is classical congenital adrenal hyperplasia, which results from a deficiency in the 21-hydroxylase enzyme...
March 2024: Curēus
https://read.qxmd.com/read/38605611/-deep-learning-based-key-frame-recognition-algorithm-for-adrenal-vascular-in-x-ray-imaging
#33
JOURNAL ARTICLE
Huimin Tao, Miao Huang, Cong Liu, Yongtian Liu, Zhihua Hu, Lili Tao, Shuping Zhang
Adrenal vein sampling is required for the staging diagnosis of primary aldosteronism, and the frames in which the adrenal veins are presented are called key frames. Currently, the selection of key frames relies on the doctor's visual judgement which is time-consuming and laborious. This study proposes a key frame recognition algorithm based on deep learning. Firstly, wavelet denoising and multi-scale vessel-enhanced filtering are used to preserve the morphological features of the adrenal veins. Furthermore, by incorporating the self-attention mechanism, an improved recognition model called ResNet50-SA is obtained...
March 30, 2024: Zhongguo Yi Liao Qi Xie za Zhi, Chinese Journal of Medical Instrumentation
https://read.qxmd.com/read/38605571/surgical-versus-medical-management-of-patients-with-primary-hyperaldosteronism-and-indeterminate-adrenal-vein-sampling-a-10-year-experience-of-the-cleveland-clinic
#34
JOURNAL ARTICLE
Chineme Onwubueke, Saif M Borgan, Huijun Xiao, Keren Zhou
In patients with primary hyperaldosteronism (PA), adrenal vein sampling (AVS) can identify patients suitable for unilateral adrenalectomy. However, in AVS with an indeterminate aldosterone-to-cortisol lateralization (ACL) ratio of 3.0-4.0, clinical guidance is unclear. The authors screened all patients undergoing AVS at the Cleveland Clinic from October 2010 to January 2021 and identified 18 patients with indeterminate ACL results. Ten underwent adrenalectomy and eight continued medical management. The surgical group was younger (58...
April 11, 2024: Journal of Clinical Hypertension
https://read.qxmd.com/read/38604339/heart-failure-with-preserved-ejection-fraction-in-the-elderly-basic-mechanisms-and-clinical-considerations
#35
REVIEW
Kimia Gharagozloo, Mozhdeh Mehdizadeh, George Heckman, Robert A Rose, Jonathan Howlett, Susan E Howlett, Stanley Nattel
Heart failure (HF) with preserved ejection fraction (HFpEF) refers to a clinical condition in which the signs of HF, such as pulmonary congestion, peripheral edema and increased natriuretic-peptide levels, are present despite normal ejection-fractions and the absence of other causes (e.g. pericardial disease). The ejection-fraction cutoff for the definition of HFpEF has varied in the past, but recent society guidelines have settled on a consensus of 50%. HFpEF is particularly common in the elderly. The aim of this narrative review is to summarize the available literature regarding HFpEF in the elderly in terms of evidence for the age-dependence, specific clinical features and underlying mechanisms...
April 9, 2024: Canadian Journal of Cardiology
https://read.qxmd.com/read/38602566/heart-failure-with-preserved-ejection-fraction-diagnosis-risk-assessment-and-treatment
#36
REVIEW
Stephan von Haehling, Birgit Assmus, Tarek Bekfani, Elke Dworatzek, Frank Edelmann, Djawid Hashemi, Kristian Hellenkamp, Tibor Kempf, Philipp Raake, Katharina A Schütt, Rolf Wachter, Paul Christian Schulze, Gerd Hasenfuss, Michael Böhm, Johann Bauersachs
The aetiology of heart failure with preserved ejection fraction (HFpEF) is heterogenous and overlaps with that of several comorbidities like atrial fibrillation, diabetes mellitus, chronic kidney disease, valvular heart disease, iron deficiency, or sarcopenia. The diagnosis of HFpEF involves evaluating cardiac dysfunction through imaging techniques and assessing increased left ventricular filling pressure, which can be measured directly or estimated through various proxies including natriuretic peptides. To better narrow down the differential diagnosis of HFpEF, European and American heart failure guidelines advocate the use of different algorithms including comorbidities that require diagnosis and rigorous treatment during the evaluation process...
April 11, 2024: Clinical Research in Cardiology: Official Journal of the German Cardiac Society
https://read.qxmd.com/read/38601279/pitfalls-in-the-preoperative-and-postoperative-workup-of-patients-with-primary-aldosteronism
#37
EDITORIAL
Marta Araujo-Castro, Iñigo García Sanz
No abstract text is available yet for this article.
March 27, 2024: Gland Surgery
https://read.qxmd.com/read/38601064/utility-of-repeat-sampling-in-bilateral-aldosterone-suppression-during-adrenal-vein-sampling-for-primary-aldosteronism
#38
Bella Halim, Eric X Z Yong, Matthew Egan, Richard J MacIsaac, David O'Neal, Nirupa Sachithanandan
Primary aldosteronism (PA) is the most common form of secondary hypertension. Accurate subtyping of PA is essential to identify unilateral disease, as adrenalectomy improves outcomes. Subtyping PA requires adrenal vein sampling (AVS), which is technically challenging and results from AVS may not always be conclusive. We present a case of a 37-year-old man with PA whose AVS studies were inconclusive due to apparent bilateral aldosterone suppression (ABAS). As a result, our patient was misdiagnosed as having bilateral PA and medically managed until a repeat AVS showed lateralization to the right adrenal gland...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38600574/factors-influencing-hospitalization-or-emergency-department-visits-and-mortality-in-type-2-diabetes-following-the-onset-of-new-cardiovascular-diagnoses-in-a-population-based-study
#39
JOURNAL ARTICLE
Björn Agvall, Junmei Miao Jonasson, Alexander Galozy, Anders Halling
BACKGROUND: Individuals with type 2 diabetes (T2D) are at increased risk of developing cardiovascular disease (CVD) which necessitates monitoring of risk factors and appropriate pharmacotherapy. This study aimed to identify factors predicting emergency department visits, hospitalizations, and mortality among T2D patients after being newly diagnosed with CVD. METHODS: In a retrospective observational study conducted in Region Halland, individuals aged > 40 years with T2D diagnosed between 2011 and 2019, and a new diagnosis of CVD between 2016 and 2019, were followed for one year from the date of CVD diagnosis...
April 10, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38597756/chronic-heart-failure-in-patients-hospitalized-in-2002-and-2021-comparative-analysis-of-prevalence-clinical-course-and-drug-therapy
#40
JOURNAL ARTICLE
A A Garganeeva, O V Tukish, K N Vitt, Yu V Mareev, E A Kuzheleva, V V Ryabov, M Yu Kondratiev, E E Syromyatnikova, B B Dorzhieva, V Yu Mareev
AIM: Comparative analysis of the prevalence of chronic heart failure (CHF), clinical and medical history data, and drug therapy of patients admitted to a cardiology hospital in 2002 and 2021. MATERIAL AND METHODS: The study analyzed the medical records of patients with a confirmed diagnosis of CHF who were admitted in 2002 (n=210) and 2021 (n=381) to a specialized cardiology hospital. RESULTS: According to medical records of 2021, the proportion of patients with a confirmed diagnosis of CHF (87...
March 31, 2024: Kardiologiia
keyword
keyword
1841
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.